- +1-315-215-1633
- sales@thebrainyinsights.com
The global drug-eluting balloon catheters market was valued at USD 657.64 million in 2022, increasing at a CAGR of 9.04% from 2022 to 2030 and anticipated to reach USD 1314.24 million by 2030. Asia Pacific is expected to grow the fastest during the forecast period. Further, the rise in the geriatric population, along with the increased government healthcare spending, is expected to propel market growth over the forecast period.
The drug-eluting balloon is a non-stent technology in which the vessel wall processes the effective homogenous delivery of anti-proliferative drugs through an inflated balloon. The balloon technology relies on the concept of targeted drug delivery, which aids in the rapid healing of the vessel wall & prevents the proliferation of smooth muscle cells. DEB technology demonstrated security & efficacy in preclinical & randomized clinical trials for patients with in-stent restenosis. DCB catheters preserve the anatomy of the vessel, facilitate improved vessel healing, and reduce the requirement for prolonged dual anti-platelet treatment without leaving any metal behind.
Get an overview of this study by requesting a free sample
Drivers:
The growing geriatric population: The ever-increasing ageing population is the driving factor of the market growth. Further, the increasing spending on healthcare and an ageing population that is more susceptible to cardiovascular diseases are also helping to drive market growth. Moreover, the increase in incidences of chronic diseases, such as cancer, neuropathy, osteoarthritis, and diabetes, is the driving factor of the market growth. Additionally, the commercialization of technologically advanced therapeutic products, favourable reimbursement policies, and changing patient demographics are also anticipated to propel the market growth during the forecast period.
Restraints:
The high cost associated with the treatment: The high price of these devices and necessary accessories is hampering the market growth. Further, the market growth in underdeveloped countries with moderately low-income levels may be restrained because of the high costs involved with catheterization procedures. The industry expansion in an emerging industry with low-income levels may be hampered by the high costs associated with drug-eluting balloon catheterization therapies. Also, the high costs associated with advanced medical devices are expected to inhibit market growth.
Opportunities:
The increasing initiatives from government and private players: The rise in technological breakthroughs & modernization in healthcare equipment, the surge in healthcare research & development activities, and growth in developing markets are creating opportunities factor of market growth. Additionally, the increasing expenditure on healthcare by the citizens & the initiatives by the federal government to raise awareness about cardiac health are anticipated to drive market growth over the forecast period. Further, new product launches due to technological improvements, collaborations, mergers, and acquisitions are the key strategic initiatives the industry players undertake that stimulate market growth over the forecast period.
Regional segmentation analysis:
The regions analyzed for the market include Europe, South America, Asia Pacific, North America, the Middle East, and Africa. North America emerged as the largest global drug-eluting balloon catheters market, with a 48.39% market revenue share in 2022. North America dominates the drug-eluting balloon catheters market due to the rising prevalence of renal failure and urological illnesses and the abundance of highly qualified surgeons, among others. Further, an increase in the number of citizens undergoing angioplasty and the USFDA's expedited permission of balloon catheters categorized as class II medical instruments are also helping to boost the market growth in this region. Additionally, the existence of a large pool of people with heart diseases and increasing healthcare spending, especially in emerging countries, are anticipated to boost the market growth in this region. Moreover, raising awareness about drug-eluting balloons and their benefits is propelling the market growth in this region during the forecast period. Additionally, Asia Pacific is expected to grow the fastest during the forecast period due to the increasing preference for and affordability of minimally invasive surgeries. Further, the growing prevalence of cardiovascular diseases in emerging industries like Brazil and India is also helping to boost the market growth in this region. Moreover, the rising medical tourism, along with the rapidly developing healthcare infrastructure, are driving market growth in this region over the forecast period.
North America Region Drug-Eluting Balloon Catheters Market Share in 2022 - 48.39%
www.thebrainyinsights.com
Check the geographical analysis of this market by requesting a free sample
Raw material segment analysis
The raw material segment is divided into nylon, polyurethane, and others. The polyurethane segment dominated, with a market share of around 41.29% in 2022. This growth is attributed to the rising demand for building insulation in light of sustainability concerns. Further, by 2030, the nylon segment will likely dominate the market due to the ever-increasing demand for nylon from automotive applications. However, nylon is a polymer, and its primary usage is to manufacture clothes fibers, fishing lines, and other textile products. Nylon has high demand in the medical market due to its ability to form strong molecular bonds.
Product segment analysis
The product segment is divided into peripheral vascular disease and coronary artery disease. In 2022, the coronary artery disease segment dominated the market, accounting for around 56.07% of global revenue. This growth is attributed to the rising prevalence of cardiovascular diseases worldwide and in emerging markets. Coronary artery disease is an advanced cardiovascular disease in which the major blood vessels that supply the heart with oxygen, blood, and nutrients (coronary arteries) become diseased or damaged. The damage in the arteries occurs due to the deposition of cholesterol in arteries, and inflammation is usually to blame for coronary artery illness. Further, by 2030, the peripheral vascular disease segment will likely dominate the market due to the increasing cases of peripheral disorders. Also, the increased usage of drug-eluting balloons in the therapy of peripheral artery diseases is helping boost the segment’s market growth.
End-user segment analysis
The end-user segment is divided into catheterization laboratories, ambulatory surgical centers, and hospitals & clinics. In 2022, the hospitals & clinics segment dominated the market, accounting for around 43.14% of global revenue. This growth is attributed to the increasing prevalence of chronic diseases such as heart diseases, blood disorders & cancers that require long-term care & treatment. Further, the rising adoption of these devices for treating cardiovascular conditions and improving blood flow via a reduction in blockage caused by fatty deposits or plaques inside arteries are also propelling the segment’s market growth. Further, by 2030, the ambulatory surgical centers’ segment will likely dominate the market due to the rising geriatric population suffering from chronic illnesses worldwide. Additionally, the requirement to reduce inpatient surgeries, especially for simple procedures, as well as the increasing acceptance of ambulatory surgical centers, are driving the segment’s market growth.
Report Description:
| Attribute | Description |
|---|---|
| Market Size | Revenue (USD Million) |
| Market size value in 2022 | USD 657.64 Million |
| Market size value in 2030 | USD 1314.24 Million |
| CAGR (2022 to 2030) | 9.04% |
| Historical data | 2019-2020 |
| Base Year | 2021 |
| Forecast | 2022-2030 |
| Segments | Key Segments are raw material, product, end-user, and regions |
| Regional Segments | The key regions are North America, South America, Europe, Asia Pacific, and Middle East & Africa. |
As per The Brainy Insights, the size of the drug-eluting balloon catheters market was valued at USD 657.64 million in 2022 to USD 1314.24 million by 2030.
The global drug-eluting balloon catheters market is growing at a CAGR of 9.04% during the forecast period 2022-2030.
North America region emerged as the largest market for drug-eluting balloon catheters.
1. Introduction
1.1. Objectives of the Study
1.2. Market Definition
1.3. Research Scope
1.4. Currency
1.5. Key Target Audience
2. Research Methodology and Assumptions
3. Executive Summary
4. Premium Insights
4.1. Porter’s Five Forces Analysis
4.2. Value Chain Analysis
4.3. Top Investment Pockets
4.3.1. Market Attractiveness Analysis By Raw Material
4.3.2. Market Attractiveness Analysis By Product
4.3.3. Market Attractiveness Analysis By End-User
4.3.4. Market Attractiveness Analysis By Region
4.4. Industry Trends
5. Market Dynamics
5.1. Market Evaluation
5.2. Drivers
5.2.1. The extensive research and development
5.2.2. The increasing incidence of chronic diseases
5.2.3. The rising government initiatives
5.2.4. The growing demand for cath labs
5.3. Restraints
5.3.1. The stringent regulatory process
5.3.2. The high cost associated with the treatment
5.4. Opportunities
5.4.1. The increasing initiatives from government and private players
6. Global Drug-Eluting Balloon Catheters Market Analysis and Forecast, By Raw Material
6.1. Segment Overview
6.2. Nylon
6.3. Polyurethane
6.4. Others
7. Global Drug-Eluting Balloon Catheters Market Analysis and Forecast, By Product
7.1. Segment Overview
7.2. Peripheral Vascular Disease
7.3. Coronary Artery Disease
8. Global Drug-Eluting Balloon Catheters Market Analysis and Forecast, By End-User
8.1. Segment Overview
8.2. Catheterization Laboratories
8.3. Ambulatory Surgical Centers
8.4. Hospitals & Clinics
9. Global Drug-Eluting Balloon Catheters Market Analysis and Forecast, By Regional Analysis
9.1. Segment Overview
9.2. North America
9.2.1. U.S.
9.2.2. Canada
9.2.3. Mexico
9.3. Europe
9.3.1. Germany
9.3.2. France
9.3.3. U.K.
9.3.4. Italy
9.3.5. Spain
9.4. Asia-Pacific
9.4.1. Japan
9.4.2. China
9.4.3. India
9.5. South America
9.5.1. Brazil
9.6. Middle East and Africa
9.6.1. UAE
9.6.2. South Africa
10. Global Drug-Eluting Balloon Catheters Market-Competitive Landscape
10.1. Overview
10.2. Market Share of Key Players in Global Drug-Eluting Balloon Catheters Market
10.2.1. Global Company Market Share
10.2.2. North America Company Market Share
10.2.3. Europe Company Market Share
10.2.4. APAC Company Market Share
10.3. Competitive Situations and Trends
10.3.1. Product Launches and Developments
10.3.2. Partnerships, Collaborations, and Agreements
10.3.3. Mergers & Acquisitions
10.3.4. Expansions
11. Company Profiles
11.1. Aachen Resonance GmbH
11.1.1. Business Overview
11.1.2. Company Snapshot
11.1.3. Company Market Share Analysis
11.1.4. Company Product Portfolio
11.1.5. Recent Developments
11.1.6. SWOT Analysis
11.2. Medtronic
11.2.1. Business Overview
11.2.2. Company Snapshot
11.2.3. Company Market Share Analysis
11.2.4. Company Product Portfolio
11.2.5. Recent Developments
11.2.6. SWOT Analysis
11.3. Biosensors International
11.3.1. Business Overview
11.3.2. Company Snapshot
11.3.3. Company Market Share Analysis
11.3.4. Company Product Portfolio
11.3.5. Recent Developments
11.3.6. SWOT Analysis
11.4. B Braun Melsungen AG
11.4.1. Business Overview
11.4.2. Company Snapshot
11.4.3. Company Market Share Analysis
11.4.4. Company Product Portfolio
11.4.5. Recent Developments
11.4.6. SWOT Analysis
11.5. Boston Scientific Corporation
11.5.1. Business Overview
11.5.2. Company Snapshot
11.5.3. Company Market Share Analysis
11.5.4. Company Product Portfolio
11.5.5. Recent Developments
11.5.6. SWOT Analysis
11.6. iVascular S L U
11.6.1. Business Overview
11.6.2. Company Snapshot
11.6.3. Company Market Share Analysis
11.6.4. Company Product Portfolio
11.6.5. Recent Developments
11.6.6. SWOT Analysis
11.7. Biotronik AG
11.7.1. Business Overview
11.7.2. Company Snapshot
11.7.3. Company Market Share Analysis
11.7.4. Company Product Portfolio
11.7.5. Recent Developments
11.7.6. SWOT Analysis
11.8. BD Interventional
11.8.1. Business Overview
11.8.2. Company Snapshot
11.8.3. Company Market Share Analysis
11.8.4. Company Product Portfolio
11.8.5. Recent Developments
11.8.6. SWOT Analysis
11.9. Lepu Medical Technology (Beijing)Co Ltd
11.9.1. Business Overview
11.9.2. Company Snapshot
11.9.3. Company Market Share Analysis
11.9.4. Company Product Portfolio
11.9.5. Recent Developments
11.9.6. SWOT Analysis
11.10. MedAlliance
11.10.1. Business Overview
11.10.2. Company Snapshot
11.10.3. Company Market Share Analysis
11.10.4. Company Product Portfolio
11.10.5. Recent Developments
11.10.6. SWOT Analysis
11.11. Eurocor GmbH
11.11.1. Business Overview
11.11.2. Company Snapshot
11.11.3. Company Market Share Analysis
11.11.4. Company Product Portfolio
11.11.5. Recent Developments
11.11.6. SWOT Analysis
11.12. Zhejiang Barty Medical Technology Co Ltd
11.12.1. Business Overview
11.12.2. Company Snapshot
11.12.3. Company Market Share Analysis
11.12.4. Company Product Portfolio
11.12.5. Recent Developments
11.12.6. SWOT Analysis
List of Table
1. Global Drug-Eluting Balloon Catheters Market, By Raw Material, 2019-2030 (USD Million)
2. Global Nylon, Drug-Eluting Balloon Catheters Market, By Region, 2019-2030 (USD Million)
3. Global Polyurethane, Drug-Eluting Balloon Catheters Market, By Region, 2019-2030 (USD Million)
4. Global Others, Drug-Eluting Balloon Catheters Market, By Region, 2019-2030 (USD Million)
5. Global Drug-Eluting Balloon Catheters Market, By Product, 2019-2030 (USD Million)
6. Global Peripheral Vascular Disease, Drug-Eluting Balloon Catheters Market, By Region, 2019-2030 (USD Million)
7. Global Coronary Artery Disease, Drug-Eluting Balloon Catheters Market, By Region, 2019-2030 (USD Million)
8. Global Drug-Eluting Balloon Catheters Market, By End-User, 2019-2030 (USD Million)
9. Global Catheterization Laboratories, Drug-Eluting Balloon Catheters Market, By Region, 2019-2030 (USD Million)
10. Global Ambulatory Surgical Centers, Drug-Eluting Balloon Catheters Market, By Region, 2019-2030 (USD Million)
11. Global Hospitals & Clinics, Drug-Eluting Balloon Catheters Market, By Region, 2019-2030 (USD Million)
12. North America Drug-Eluting Balloon Catheters Market, By Raw Material, 2019-2030 (USD Million)
13. North America Drug-Eluting Balloon Catheters Market, By Product, 2019-2030 (USD Million)
14. North America Drug-Eluting Balloon Catheters Market, By End-User, 2019-2030 (USD Million)
15. U.S. Drug-Eluting Balloon Catheters Market, By Raw Material, 2019-2030 (USD Million)
16. U.S. Drug-Eluting Balloon Catheters Market, By Product, 2019-2030 (USD Million)
17. U.S. Drug-Eluting Balloon Catheters Market, By End-User, 2019-2030 (USD Million)
18. Canada Drug-Eluting Balloon Catheters Market, By Raw Material, 2019-2030 (USD Million)
19. Canada Drug-Eluting Balloon Catheters Market, By Product, 2019-2030 (USD Million)
20. Canada Drug-Eluting Balloon Catheters Market, By End-User, 2019-2030 (USD Million)
21. Mexico Drug-Eluting Balloon Catheters Market, By Raw Material, 2019-2030 (USD Million)
22. Mexico Drug-Eluting Balloon Catheters Market, By Product, 2019-2030 (USD Million)
23. Mexico Drug-Eluting Balloon Catheters Market, By End-User, 2019-2030 (USD Million)
24. Europe Drug-Eluting Balloon Catheters Market, By Raw Material, 2019-2030 (USD Million)
25. Europe Drug-Eluting Balloon Catheters Market, By Product, 2019-2030 (USD Million)
26. Europe Drug-Eluting Balloon Catheters Market, By End-User, 2019-2030 (USD Million)
27. Germany Drug-Eluting Balloon Catheters Market, By Raw Material, 2019-2030 (USD Million)
28. Germany Drug-Eluting Balloon Catheters Market, By Product, 2019-2030 (USD Million)
29. Germany Drug-Eluting Balloon Catheters Market, By End-User, 2019-2030 (USD Million)
30. France Drug-Eluting Balloon Catheters Market, By Raw Material, 2019-2030 (USD Million)
31. France Drug-Eluting Balloon Catheters Market, By Product, 2019-2030 (USD Million)
32. France Drug-Eluting Balloon Catheters Market, By End-User, 2019-2030 (USD Million)
33. U.K. Drug-Eluting Balloon Catheters Market, By Raw Material, 2019-2030 (USD Million)
34. U.K. Drug-Eluting Balloon Catheters Market, By Product, 2019-2030 (USD Million)
35. U.K. Drug-Eluting Balloon Catheters Market, By End-User, 2019-2030 (USD Million)
36. Italy Drug-Eluting Balloon Catheters Market, By Raw Material, 2019-2030 (USD Million)
37. Italy Drug-Eluting Balloon Catheters Market, By Product, 2019-2030 (USD Million)
38. Italy Drug-Eluting Balloon Catheters Market, By End-User, 2019-2030 (USD Million)
39. Spain Drug-Eluting Balloon Catheters Market, By Raw Material, 2019-2030 (USD Million)
40. Spain Drug-Eluting Balloon Catheters Market, By Product, 2019-2030 (USD Million)
41. Spain Drug-Eluting Balloon Catheters Market, By End-User, 2019-2030 (USD Million)
42. Asia Pacific Drug-Eluting Balloon Catheters Market, By Raw Material, 2019-2030 (USD Million)
43. Asia Pacific Drug-Eluting Balloon Catheters Market, By Product, 2019-2030 (USD Million)
44. Asia Pacific Drug-Eluting Balloon Catheters Market, By End-User, 2019-2030 (USD Million)
45. Japan Drug-Eluting Balloon Catheters Market, By Raw Material, 2019-2030 (USD Million)
46. Japan Drug-Eluting Balloon Catheters Market, By Product, 2019-2030 (USD Million)
47. Japan Drug-Eluting Balloon Catheters Market, By End-User, 2019-2030 (USD Million)
48. China Drug-Eluting Balloon Catheters Market, By Raw Material, 2019-2030 (USD Million)
49. China Drug-Eluting Balloon Catheters Market, By Product, 2019-2030 (USD Million)
50. China Drug-Eluting Balloon Catheters Market, By End-User, 2019-2030 (USD Million)
51. India Drug-Eluting Balloon Catheters Market, By Raw Material, 2019-2030 (USD Million)
52. India Drug-Eluting Balloon Catheters Market, By Product, 2019-2030 (USD Million)
53. India Drug-Eluting Balloon Catheters Market, By End-User, 2019-2030 (USD Million)
54. South America Drug-Eluting Balloon Catheters Market, By Raw Material, 2019-2030 (USD Million)
55. South America Drug-Eluting Balloon Catheters Market, By Product, 2019-2030 (USD Million)
56. South America Drug-Eluting Balloon Catheters Market, By End-User, 2019-2030 (USD Million)
57. Brazil Drug-Eluting Balloon Catheters Market, By Raw Material, 2019-2030 (USD Million)
58. Brazil Drug-Eluting Balloon Catheters Market, By Product, 2019-2030 (USD Million)
59. Brazil Drug-Eluting Balloon Catheters Market, By End-User, 2019-2030 (USD Million)
60. Middle East and Africa Drug-Eluting Balloon Catheters Market, By Raw Material, 2019-2030 (USD Million)
61. Middle East and Africa Drug-Eluting Balloon Catheters Market, By Product, 2019-2030 (USD Million)
62. Middle East and Africa Drug-Eluting Balloon Catheters Market, By End-User, 2019-2030 (USD Million)
63. UAE Drug-Eluting Balloon Catheters Market, By Raw Material, 2019-2030 (USD Million)
64. UAE Drug-Eluting Balloon Catheters Market, By Product, 2019-2030 (USD Million)
65. UAE Drug-Eluting Balloon Catheters Market, By End-User, 2019-2030 (USD Million)
66. South Africa Drug-Eluting Balloon Catheters Market, By Raw Material, 2019-2030 (USD Million)
67. South Africa Drug-Eluting Balloon Catheters Market, By Product, 2019-2030 (USD Million)
68. South Africa Drug-Eluting Balloon Catheters Market, By End-User, 2019-2030 (USD Million)
List of Figures
1. Global Drug-Eluting Balloon Catheters Market Segmentation
2. Global Drug-Eluting Balloon Catheters Market: Research Methodology
3. Market Size Estimation Methodology: Bottom-Up Approach
4. Market Size Estimation Methodology: Top- Approach
5. Data Triangulation
6. Porter’s Five Forces Analysis
7. Value Chain Analysis
8. Global Drug-Eluting Balloon Catheters Market Attractiveness Analysis By Raw Material
9. Global Drug-Eluting Balloon Catheters Market Attractiveness Analysis By Product
10. Global Drug-Eluting Balloon Catheters Market Attractiveness Analysis By End-User
11. Global Drug-Eluting Balloon Catheters Market Attractiveness Analysis By Region
12. Global Drug-Eluting Balloon Catheters Market: Dynamics
13. Global Drug-Eluting Balloon Catheters Market Share By Raw Material (2022 & 2030)
14. Global Drug-Eluting Balloon Catheters Market Share By Product (2022 & 2030)
15. Global Drug-Eluting Balloon Catheters Market Share By End-User (2022 & 2030)
16. Global Drug-Eluting Balloon Catheters Market Share By Regions (2022 & 2030)
17. Global Drug-Eluting Balloon Catheters Market Share By Company (2021)
This study forecasts revenue at global, regional, and country levels from 2019 to 2030. The Brainy Insights has segmented the global drug-eluting balloon catheters based on below mentioned segments:
Global Drug-Eluting Balloon Catheters Market by Raw Material:
Global Drug-Eluting Balloon Catheters Market by Product:
Global Drug-Eluting Balloon Catheters Market by End-User:
Global Drug-Eluting Balloon Catheters by Region:
Research has its special purpose to undertake marketing efficiently. In this competitive scenario, businesses need information across all industry verticals; the information about customer wants, market demand, competition, industry trends, distribution channels etc. This information needs to be updated regularly because businesses operate in a dynamic environment. Our organization, The Brainy Insights incorporates scientific and systematic research procedures in order to get proper market insights and industry analysis for overall business success. The analysis consists of studying the market from a miniscule level wherein we implement statistical tools which helps us in examining the data with accuracy and precision.
Our research reports feature both; quantitative and qualitative aspects for any market. Qualitative information for any market research process are fundamental because they reveal the customer needs and wants, usage and consumption for any product/service related to a specific industry. This in turn aids the marketers/investors in knowing certain perceptions of the customers. Qualitative research can enlighten about the different product concepts and designs along with unique service offering that in turn, helps define marketing problems and generate opportunities. On the other hand, quantitative research engages with the data collection process through interviews, e-mail interactions, surveys and pilot studies. Quantitative aspects for the market research are useful to validate the hypotheses generated during qualitative research method, explore empirical patterns in the data with the help of statistical tools, and finally make the market estimations.
The Brainy Insights offers comprehensive research and analysis, based on a wide assortment of factual insights gained through interviews with CXOs and global experts and secondary data from reliable sources. Our analysts and industry specialist assume vital roles in building up statistical tools and analysis models, which are used to analyse the data and arrive at accurate insights with exceedingly informative research discoveries. The data provided by our organization have proven precious to a diverse range of companies, facilitating them to address issues such as determining which products/services are the most appealing, whether or not customers use the product in the manner anticipated, the purchasing intentions of the market and many others.
Our research methodology encompasses an idyllic combination of primary and secondary initiatives. Key phases involved in this process are listed below:
The phase involves the gathering and collecting of market data and its related information with the help of different sources & research procedures.
The data procurement stage involves in data gathering and collecting through various data sources.
This stage involves in extensive research. These data sources includes:
Purchased Database: Purchased databases play a crucial role in estimating the market sizes irrespective of the domain. Our purchased database includes:
Primary Research: The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. Primary research mainly involves in telephonic interviews, E-mail interactions and face-to-face interviews with the raw material providers, manufacturers/producers, distributors, & independent consultants. The interviews that we conduct provides valuable data on market size and industry growth trends prevailing in the market. Our organization also conducts surveys with the various industry experts in order to gain overall insights of the industry/market. For instance, in healthcare industry we conduct surveys with the pharmacists, doctors, surgeons and nurses in order to gain insights and key information of a medical product/device/equipment which the customers are going to usage. Surveys are conducted in the form of questionnaire designed by our own analyst team. Surveys plays an important role in primary research because surveys helps us to identify the key target audiences of the market. Additionally, surveys helps to identify the key target audience engaged with the market. Our survey team conducts the survey by targeting the key audience, thus gaining insights from them. Based on the perspectives of the customers, this information is utilized to formulate market strategies. Moreover, market surveys helps us to understand the current competitive situation of the industry. To be precise, our survey process typically involve with the 360 analysis of the market. This analytical process begins by identifying the prospective customers for a product or service related to the market/industry to obtain data on how a product/service could fit into customers’ lives.
Secondary Research: The secondary data sources includes information published by the on-profit organizations such as World bank, WHO, company fillings, investor presentations, annual reports, national government documents, statistical databases, blogs, articles, white papers and others. From the annual report, we analyse a company’s revenue to understand the key segment and market share of that organization in a particular region. We analyse the company websites and adopt the product mapping technique which is important for deriving the segment revenue. In the product mapping method, we select and categorize the products offered by the companies catering to domain specific market, deduce the product revenue for each of the companies so as to get overall estimation of the market size. We also source data and analyses trends based on information received from supply side and demand side intermediaries in the value chain. The supply side denotes the data gathered from supplier, distributor, wholesaler and the demand side illustrates the data gathered from the end customers for respective market domain.
The supply side for a domain specific market is analysed by:
The demand side for the market is estimated through:
In-house Library: Apart from these third-party sources, we have our in-house library of qualitative and quantitative information. Our in-house database includes market data for various industry and domains. These data are updated on regular basis as per the changing market scenario. Our library includes, historic databases, internal audit reports and archives.
Sometimes there are instances where there is no metadata or raw data available for any domain specific market. For those cases, we use our expertise to forecast and estimate the market size in order to generate comprehensive data sets. Our analyst team adopt a robust research technique in order to produce the estimates:
Data Synthesis: This stage involves the analysis & mapping of all the information obtained from the previous step. It also involves in scrutinizing the data for any discrepancy observed while data gathering related to the market. The data is collected with consideration to the heterogeneity of sources. Robust scientific techniques are in place for synthesizing disparate data sets and provide the essential contextual information that can orient market strategies. The Brainy Insights has extensive experience in data synthesis where the data passes through various stages:
Market Deduction & Formulation: The final stage comprises of assigning data points at appropriate market spaces so as to deduce feasible conclusions. Analyst perspective & subject matter expert based holistic form of market sizing coupled with industry analysis also plays a crucial role in this stage.
This stage involves in finalization of the market size and numbers that we have collected from data integration step. With data interpolation, it is made sure that there is no gap in the market data. Successful trend analysis is done by our analysts using extrapolation techniques, which provide the best possible forecasts for the market.
Data Validation & Market Feedback: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helps us finalize data-points to be used for final calculations.
The Brainy Insights interacts with leading companies and experts of the concerned domain to develop the analyst team’s market understanding and expertise. It improves and substantiates every single data presented in the market reports. The data validation interview and discussion panels are typically composed of the most experienced industry members. The participants include, however, are not limited to:
Moreover, we always validate our data and findings through primary respondents from all the major regions we are working on.
Free Customization
Fortune 500 Clients
Free Yearly Update On Purchase Of Multi/Corporate License
Companies Served Till Date
